<DOC>
	<DOCNO>NCT02572778</DOCNO>
	<brief_summary>The investigator want collection fresh primary recurrent tumor tissue establishment patients-derived xenograft order : generate biobank vivo patient xenograft represent different subgroup tumor head neck cancer - perform genetic transcriptional profiling primary , metastatic tumor xenograft tumor - evaluate efficacy new target agent , whether combination standard treatment option - evaluate biomarkers drug sensitivity - study primary secondary ( acquire ) resistance model</brief_summary>
	<brief_title>Patient-derived Xenograft Models Tumor From Patients With Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>In first phase , patient primary recurrent/ metastatic disease head neck cancer include preoperatively tumor biopsy obtain informed consent Data stage , grade , histology , adjuvant treatment , response , relapse available Followup data available Patients recurrent disease allow Written inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>